chevron_leftBack
As of 13 June 2026, SyntekaBio, Inc. has a market cap of $51.6M USD, ranking #30377 globally and #1722 in South Korea.
It ranks #4560 in the Technology sector, and #1369 in the Software - Application industry.
Key Stats
Market Cap
$51.6MUSD
78.48B KRW
Enterprise Value
$45.38MUSD
69.26B KRW
Revenue (TTM)
$2.25MUSD
3.43B KRW
EBITDA (TTM)
-$5.73MUSD
-8.74B KRW
Net Income (TTM)
-$11.43MUSD
-17.38B KRW
EBITDA Margin
-255%
PS Ratio
22.9
PB Ratio
2.5
Company Profile
Country (HQ)
Sector
Technology
Industry
Software - Application
CEO
Jong Sun Jung
open_in_new
Founded
2009
Website
syntekabio.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.5% | 1.3% | -6% | -16% | -19% | -55% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
226330
(주)신테카바이오 Ordinary Shares
ISIN: KR7226330009
Shares Out.:
Shares Outstanding:
24.259M1
Shares Float:
20.421M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
3,235 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About SyntekaBio, Inc.
SyntekaBio, Inc. operates as an artificial intelligence new drug development company based on genomic big data primarily in South Korea. It derives new drug candidates using DeepMatcher, an AI drug development platform that combines new drug development technology and genomic big data technology. The company also researches and develops biomarker detection for individual cancer drug screening, disease susceptibility, immune typing, pharmacogenomic typing, and multi-omics information-based drug side effect prediction technology. The company was founded in 2009 and is headquartered in Daejeon, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 035420
|
$21.64B
42K%
32.91T KRW
|
17.0
|
|
KRX: 259960
|
$8.15B
16K%
12.39T KRW
|
17.0
|
|
KRX: 036570
|
$3.54B
7K%
5.38T KRW
|
15.5
|
|
KRX: 251270
|
$2.54B
5K%
3.87T KRW
|
18.6
|
|
KRX: 263750
|
$2.42B
5K%
3.68T KRW
|
-
|
|
KRX: 012510
|
$2.21B
4K%
3.36T KRW
|
38.7
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: GOOG
|
$4.23T
8M%
|
32.0
|
|
NASDAQ: MSFT
|
$3.15T
6M%
|
26.6
|
|
NASDAQ: META
|
$1.7T
3M%
|
28.5
|
|
SHEK: 700
|
$551.54B
1M%
4.32T HKD
|
17.8
|
|
NYSE: ORCL
|
$471.18B
913K%
|
29.4
|
|
NASDAQ: NFLX
|
$387.9B
752K%
|
29.8
|
chevron_leftBack